A Prospective Study of Taxane-Induced Neuropathy with Breast Cancer: Proper Assessment Tool for Taxane-Induced Neuropathy

Background Many chemotherapeutic agents, especially taxanes, can induce peripheral neuropathy. Aim To evaluate the clinical characteristics of taxane-induced neuropathy (TIN) and determine the proper assessment tool for TIN in patients with breast cancer. Setting and Design Sin...

Full description

Bibliographic Details
Main Authors: Eun Hee Sohn, Jin Sun Lee, Mi Sook Jung, Je Ryong Kim
Format: Article
Language:English
Published: Thieme Medical and Scientific Publishers Pvt. Ltd. 2021-04-01
Series:South Asian Journal of Cancer
Subjects:
Online Access:http://www.thieme-connect.de/DOI/DOI?10.1055/s-0041-1731100
id doaj-2f0ffb7667b44514b91b8cd623472d48
record_format Article
spelling doaj-2f0ffb7667b44514b91b8cd623472d482021-09-23T22:32:09ZengThieme Medical and Scientific Publishers Pvt. Ltd.South Asian Journal of Cancer2278-330X2278-43062021-04-011002586310.1055/s-0041-1731100A Prospective Study of Taxane-Induced Neuropathy with Breast Cancer: Proper Assessment Tool for Taxane-Induced NeuropathyEun Hee Sohn0Jin Sun Lee1Mi Sook Jung2Je Ryong Kim3Department of Neurology, Chungnam National University Hospital, KoreaDepartment of Surgery and Research Institute for Medical Sciences, College of Medicine, Chungnam National University, KoreaCollege of Nursing, Chungnam National University, Daejeon, KoreaDepartment of Surgery and Research Institute for Medical Sciences, College of Medicine, Chungnam National University, KoreaBackground Many chemotherapeutic agents, especially taxanes, can induce peripheral neuropathy. Aim To evaluate the clinical characteristics of taxane-induced neuropathy (TIN) and determine the proper assessment tool for TIN in patients with breast cancer. Setting and Design Single-center, observational, prospective study. Methods and Material Forty-three patients with breast cancer treated with taxanes were prospectively enrolled. The reduced version of the Total Neuropathy Score (TNSr) was performed at baseline and 3 months after enrollment. TIN was diagnosed if the difference between the baseline and 3-month TNSr was greater than 1. In patients with TIN, the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire— Chemotherapy-Induced Peripheral Neuropathy (20-item scale (EORTC-CIPN20) was also assessed 3 months after enrollment. Results Thirty-seven out of 43 (86.0%) patients were diagnosed with TIN. Sensory symptoms (64.9%) were the most frequent abnormality, followed by autonomic symptoms (54.1%). No patients reported motor symptoms or motor weakness. The TNSr sensory symptom score positively correlated with that of the EORTC-CIPN20. Nerve conduction studies showed reduced nerve conduction velocities and amplitudes after taxane treatment compared to those before chemotherapy in all tested nerves; however, only three (8.1%) patients had sural sensory nerve action potential amplitude outside normal limits. Conclusions TIN was predominantly sensory with normal nerve conduction studies which is the main feature of small fiber neuropathy. A combination scale comprising of a clinician-based scale and a patient-reported questionnaire and specialized tests for small nerve fibers should be considered as proper assessment tools to evaluate TIN.http://www.thieme-connect.de/DOI/DOI?10.1055/s-0041-1731100breast neoplasmstaxaneperipheral nervous system diseasessmall fiber neuropathy
collection DOAJ
language English
format Article
sources DOAJ
author Eun Hee Sohn
Jin Sun Lee
Mi Sook Jung
Je Ryong Kim
spellingShingle Eun Hee Sohn
Jin Sun Lee
Mi Sook Jung
Je Ryong Kim
A Prospective Study of Taxane-Induced Neuropathy with Breast Cancer: Proper Assessment Tool for Taxane-Induced Neuropathy
South Asian Journal of Cancer
breast neoplasms
taxane
peripheral nervous system diseases
small fiber neuropathy
author_facet Eun Hee Sohn
Jin Sun Lee
Mi Sook Jung
Je Ryong Kim
author_sort Eun Hee Sohn
title A Prospective Study of Taxane-Induced Neuropathy with Breast Cancer: Proper Assessment Tool for Taxane-Induced Neuropathy
title_short A Prospective Study of Taxane-Induced Neuropathy with Breast Cancer: Proper Assessment Tool for Taxane-Induced Neuropathy
title_full A Prospective Study of Taxane-Induced Neuropathy with Breast Cancer: Proper Assessment Tool for Taxane-Induced Neuropathy
title_fullStr A Prospective Study of Taxane-Induced Neuropathy with Breast Cancer: Proper Assessment Tool for Taxane-Induced Neuropathy
title_full_unstemmed A Prospective Study of Taxane-Induced Neuropathy with Breast Cancer: Proper Assessment Tool for Taxane-Induced Neuropathy
title_sort prospective study of taxane-induced neuropathy with breast cancer: proper assessment tool for taxane-induced neuropathy
publisher Thieme Medical and Scientific Publishers Pvt. Ltd.
series South Asian Journal of Cancer
issn 2278-330X
2278-4306
publishDate 2021-04-01
description Background Many chemotherapeutic agents, especially taxanes, can induce peripheral neuropathy. Aim To evaluate the clinical characteristics of taxane-induced neuropathy (TIN) and determine the proper assessment tool for TIN in patients with breast cancer. Setting and Design Single-center, observational, prospective study. Methods and Material Forty-three patients with breast cancer treated with taxanes were prospectively enrolled. The reduced version of the Total Neuropathy Score (TNSr) was performed at baseline and 3 months after enrollment. TIN was diagnosed if the difference between the baseline and 3-month TNSr was greater than 1. In patients with TIN, the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire— Chemotherapy-Induced Peripheral Neuropathy (20-item scale (EORTC-CIPN20) was also assessed 3 months after enrollment. Results Thirty-seven out of 43 (86.0%) patients were diagnosed with TIN. Sensory symptoms (64.9%) were the most frequent abnormality, followed by autonomic symptoms (54.1%). No patients reported motor symptoms or motor weakness. The TNSr sensory symptom score positively correlated with that of the EORTC-CIPN20. Nerve conduction studies showed reduced nerve conduction velocities and amplitudes after taxane treatment compared to those before chemotherapy in all tested nerves; however, only three (8.1%) patients had sural sensory nerve action potential amplitude outside normal limits. Conclusions TIN was predominantly sensory with normal nerve conduction studies which is the main feature of small fiber neuropathy. A combination scale comprising of a clinician-based scale and a patient-reported questionnaire and specialized tests for small nerve fibers should be considered as proper assessment tools to evaluate TIN.
topic breast neoplasms
taxane
peripheral nervous system diseases
small fiber neuropathy
url http://www.thieme-connect.de/DOI/DOI?10.1055/s-0041-1731100
work_keys_str_mv AT eunheesohn aprospectivestudyoftaxaneinducedneuropathywithbreastcancerproperassessmenttoolfortaxaneinducedneuropathy
AT jinsunlee aprospectivestudyoftaxaneinducedneuropathywithbreastcancerproperassessmenttoolfortaxaneinducedneuropathy
AT misookjung aprospectivestudyoftaxaneinducedneuropathywithbreastcancerproperassessmenttoolfortaxaneinducedneuropathy
AT jeryongkim aprospectivestudyoftaxaneinducedneuropathywithbreastcancerproperassessmenttoolfortaxaneinducedneuropathy
AT eunheesohn prospectivestudyoftaxaneinducedneuropathywithbreastcancerproperassessmenttoolfortaxaneinducedneuropathy
AT jinsunlee prospectivestudyoftaxaneinducedneuropathywithbreastcancerproperassessmenttoolfortaxaneinducedneuropathy
AT misookjung prospectivestudyoftaxaneinducedneuropathywithbreastcancerproperassessmenttoolfortaxaneinducedneuropathy
AT jeryongkim prospectivestudyoftaxaneinducedneuropathywithbreastcancerproperassessmenttoolfortaxaneinducedneuropathy
_version_ 1717370318717190144